Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

Cited by (1,000)

Items 101–200 of 1,000

1. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations
   Jennifer A. Oberg, Julia Glade Bender, Maria Luisa Sulis, Danielle Pendrick, Anthony N. Sireci, Susan Jean Hsiao, Andrew T. Turk, Filemon S. Dela Cruz, Hanina H. Hibshoosh, Helen Elaine Remotti et al. · 2016 · Genome Medicine
2. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia
   Joshua Yew-Suang Lim, Ravi Bhatia, Leslie L. Robison, Jun J.J. Yang · 2013 · Cancer
3. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
   Ching‐Hon Pui, Kim E. Nichols, Jun J.J. Yang · 2018 · Nature Reviews Clinical Oncology
4. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
   Dalma Müller, Balázs Győrffy · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
5. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
   Mignon L. Loh, Jinghui Zhang, Richard C. Harvey, Kathryn G. Roberts, Debbie Payne-Turner, Huining Kang, Gang Wu, Xiang 'Anthony' Chen, Jared B. Becksfort, Michael N. Edmonson et al. · 2012 · Blood
6. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
   Sabina Chiaretti, A. Vitale, Giovanni Cazzaniga, S. M. Orlando, Daniela Silvestri, Paola Fazi, Maria Grazia Valsecchi, L Elia, A. M. Testi, F. Mancini et al. · 2013 · Haematologica
7. Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
   Étienne Lengliné, Kheïra Beldjord, Hervé Dombret, Jean Soulier, Nicolas Boissel, Emmanuelle Clappier · 2013 · Haematologica
8. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency
   Boutboul, David, Kuehn, Hye Sun, Van de Wyngaert, Zoé, Niemela, Julie E., Callebaut, Isabelle, Stoddard, Jennifer, Lenoir, Christelle, Barlogis, Vincent, Farnarier, Catherine, Vely, Frédéric et al. · 2018 · Journal of Clinical Investigation
9. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia
   Stephen P. Hunger, Mignon L. Loh, James A. Whitlock, Naomi Joan Winick, William L. Carroll, Meenakshi Devidas, Elizabeth A. Raetz · 2012 · Pediatric Blood & Cancer
10. Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis
    Tobias Herold, Stephanie Schneider, Klaus Hans Metzeler, Martín Neumann, Luise Hartmann, Kathryn G. Roberts, Nikola P. Konstandin, Philipp A. Greif, Kathrin Bräundl, Bianka Ksienzyk et al. · 2016 · Haematologica
11. Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL
    Yaqi Zhao, Ibrahim Taha Aldoss, Chunxu Qu, Jeremy Chase Crawford, Zhaohui Gu, Emma Kaitlynn Allen, Anthony Elston Zamora, Thomas Alexander, Jeremy Wang, Hiroaki Goto et al. · 2020 · Blood
12. Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
    Sarah Kathleen Tasian, David T. Teachey, Yong Li, Feng Shen, Richard C. Harvey, I‐Ming Chen, Theresa M. Ryan, Tiffaney L. Vincent, Cheryl L. Willman, Alexander E. Perl et al. · 2016 · Blood
13. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
    Petra Dörge, B. Meissner, M Zimmermann, Anja Möricke, André Schrauder, Jean-Pierre Bouquin, Denis Martin Schewe, Jochen Harbott, Andrea Teigler‐Schlegel, Richard Ratei et al. · 2012 · Haematologica
14. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
    René Marke, Frank N. van Leeuwen, Blanca Scheijen · 2018 · Haematologica
15. Advances in germline predisposition to acute leukaemias and myeloid neoplasms
    Jeffery M. Klco, Charles Grenfell Mullighan · 2020 · Nature reviews. Cancer
16. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia
    Patricia Stow, Laura Key, Xiaohua Chen, Qiulu Pan, Geoffrey A. M. Neale, Elaine Coustan‐Smith, Charles Grenfell Mullighan, Yinmei Zhou, Ching‐Hon Pui, Dario Campana · 2010 · Blood
17. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia
    Ila Joshi, Toshimi Yoshida, Nilamani Jena, Xiaoqing Qi, Jiangwen Zhang, Richard A. Van Etten, Katia Georgopoulos · 2014 · Nature Immunology
18. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
    Lynn M. Heltemes-Harris, Mark Willette, Laura B. Ramsey, Yi Hua Qiu, E. Shannon Neeley, Nianxiang Zhang, Deborah Ann Thomas, Thearith Koeuth, Emily C. Baechler, Steven Mitchell Kornblau et al. · 2011 · The Journal of Experimental Medicine
19. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features
    Claire J. Schwab, Lucy Chilton, H. Morrison, L. Jones, Halima A Al-Shehhi, A. Erhorn, Lisa Jane Russell, Anthony V. Moorman, Christine J. Harrison · 2013 · Haematologica
20. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
    Mario Cazzola · 2016 · Blood
21. Genomic subtyping and therapeutic targeting of acute erythroleukemia
    Iacobucci, Ilaria, Wen, Ji, Meggendorfer, Manja, Choi, John K., Shi, Lei, Pounds, Stanley B., Carmichael, Catherine L., Masih, Katherine E., Morris, Sarah M., Lindsley, R. Coleman et al. · 2019 · Nature Genetics
22. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion
    Marco Lucioni, Francesca Novara, Giacomo Fiandrino, Roberta Riboni, Daniele Fanoni, Mariarosa Arra, Luigia Venegoni, Marta Di Nicola, Elena Dallera, Luca Arcaini et al. · 2011 · Blood
23. Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Kathrin Maria Bernt, Stephen P. Hunger · 2014 · Frontiers in Oncology
24. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
    Emmanuelle Clappier, Auclerc Mf, Jérôme Rapion, Marleen H. C. Bakkus, Aurélie Caye‐Eude, A. Khemiri, Claudine Giroux, Lucie Hernandez, Emmanuelle Kabongo, Suvi P. Savola et al. · 2013 · Leukemia
25. Management of ALL in adults: 2024 ELN recommendations from a European expert panel
    Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele Kay Fielding, Robin Foà, Sebastian Giebel, Dieter F. Hoelzer, Mathilde Hunault et al. · 2024 · Blood
26. IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL
    Arian van der Veer, Marketa Kubricanova Zaliova, Federica Mottadelli, Paola De Lorenzo, Geertruy te Kronnie, Christine J. Harrison, Hélène Cavé, Jan Trka, Vaskar Saha, Martin Schrappe et al. · 2013 · Blood
27. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
    Philipp A. Greif, Annika Maria Dufour, Nikola P. Konstandin, Bianka Ksienzyk, Evelyn Zellmeier, Belay Tizazu, Jutta Sturm, Tobias Benthaus, Tobias Herold, Marjan Yaghmaie et al. · 2012 · Blood
28. Cytogenetics and Molecular Genetics of Acute Lymphoblastic Leukemia
    Krzysztof Mrózek, David P. Harper, Peter D. Aplan · 2009 · Hematology/Oncology Clinics of North America
29. Inherited genetic variation in childhood acute lymphoblastic leukemia
    Takaya Moriyama, Mary V. Relling, Jun J.J. Yang · 2015 · Blood
30. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions
    Charles Grenfell Mullighan, James R. Downing · 2009 · Leukemia
31. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia
    Ilaria Iacobucci, Yongjin Li, Kathryn G. Roberts, Stephanie M. Dobson, Jaeseung C. Kim, Debbie Payne-Turner, Richard C. Harvey, Marcus L Valentine, Kelly McCastlain, John B. Easton et al. · 2016 · Cancer Cell
32. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
    Robert John Arceci · 2010 · Yearbook of Oncology
33. Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
    Esmé Waanders, Zhaohui Gu, Stephanie M. Dobson, Željko Antić, Jeremy Chase Crawford, Xiaotu Ma, Michael N. Edmonson, Debbie Payne-Turner, Maartje van de Vorst, Marjolijn C.J. Jongmans et al. · 2020 · Blood Cancer Discovery
34. Prognostic factors in adult acute lymphoblastic leukaemia
    Jacob M. Rowe · 2010 · British Journal of Haematology
35. Infection Exposure Is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5 -Inherited Susceptibility
    Alberto Martín‐Lorenzo, Julia Hauer, Carolina Vicente‐Dueñas, Franziska Auer, Inés González‐Herrero, Idoia García‐Ramírez, Sebastian Ginzel, Ralf Thiele, Stefan N. Constantinescu, Christoph Bartenhagen et al. · 2015 · Cancer Discovery
36. Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics
    Hömig-Hölzel Cornelia, Suvi P. Savola · 2012 · Diagnostic Molecular Pathology
37. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia
    María E. Figueroa, Shann-Ching Chen, Anna Andersson, Letha A. Phillips, Yushan Li, Jason R. Sotzen, Mondira Kundu, James R. Downing, Ari M. Melnick, Charles Grenfell Mullighan · 2013 · Journal of Clinical Investigation
38. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities
    Thai Hoa Tran, Stephen P. Hunger · 2020 · Seminars in Cancer Biology
39. Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression
    Shibin Ma, Simanta Pathak, Malay Mandal, Long Trinh, Marcus R. Clark, Runqing Lu · 2010 · Molecular and Cellular Biology
40. Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
    Jan, Max, Sperling, Adam S., Ebert, Benjamin L. · 2021 · Nature Reviews Clinical Oncology
41. Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
    Roland Jäger, Heinz Gisslinger, Francesco Passamonti, Elisa Rumi, Tobias Berg, Bettina Gisslinger, Daniela Pietra, Ashot S. Harutyunyan, Thorsten Klampfl, Damla Olcaydu et al. · 2010 · Leukemia
42. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia
    Somasundaram, Rajesh, Prasad, Mahadesh A. J., Ungerbäck, Jonas, Sigvardsson, Mikael · 2015 · Blood
43. Minimal Residual Disease–Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 Study
    Allen Eng Juh Yeoh, Hany Ariffin, Elaine Li Leng Chai, Cecilia Sze Nga Kwok, Yiong Huak Chan, Ponnudurai Kuperan, Dario Campana, Poh Lin Tan, Mei Yoke Chan, Shirley Kow Yin Kham et al. · 2012 · Journal of Clinical Oncology
44. Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma
    James V. Tricoli, Donald G. Blair, Carey K. Anders, W. Archie Bleyer, Lisa A. Boardman, Javed Iqbal Khan, Shivaani Kummar, Brandon Hayes‐Lattin, Stephen P. Hunger, Melinda S. Merchant et al. · 2016 · Cancer
45. Philadelphia Chromosome–like Acute Lymphoblastic Leukemia
    Ching‐Hon Pui, Kathryn G. Roberts, Jun J.J. Yang, Charles Grenfell Mullighan · 2017 · Clinical Lymphoma Myeloma & Leukemia
46. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
    Rashmi B. Prasad, Fay J. Hosking, Jayaram Vijayakrishnan, Elli Papaemmanuil, Rolf Koehler, Melvyn F. Greaves, Eamonn G. Sheridan, Andreas Gast, Sally E. Kinsey, Tracy J. Lightfoot et al. · 2009 · Blood
47. Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein
    Haiying Qin, Monica Cho, Waleed M. Haso, Ling Zhang, Sarah Kathleen Tasian, Htoo Zarni Oo, Gian Luca Negri, Yongshun Lin, Jizhong Zou, Barbara S. Mallon et al. · 2015 · Blood
48. Landscape and function of multiple mutations within individual oncogenes
    Yuki Saito, Junji Koya, Mitsugu Araki, Yasunori Kogure, Sumito Shingaki, Mariko Tabata, Marni B. McClure, Kota Yoshifuji, Shigeyuki Matsumoto, Yuta Isaka et al. · 2020 · Nature
49. Adolescent and young adult patients with cancer: a milieu of unique features
    Sender, Leonard, Zabokrtsky, Keri B. · 2015 · Nature Reviews Clinical Oncology
50. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers
    Serena Pillozzi, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei, Marinella Veltroni, Massimo D’Amico, Giuseppe Basso et al. · 2010 · Blood
51. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
    Esmé Waanders, Vincent H. J. van der Velden, C. Ellen van der Schoot, Frank N. van Leeuwen, Simon V. van Reijmersdal, Válerie de Haas, Anjo J.P. Veerman, Ad Geurts van Kessel, Peter M. Hoogerbrugge, Roland P. Kuiper et al. · 2010 · Leukemia
52. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children’s Oncology Group
    Kathryn G. Roberts, Shalini C. Reshmi, Richard C. Harvey, I‐Ming Chen, Kinnari Patel, Eileen Stonerock, Heather Jenkins, Yunfeng E. Dai, Marc B. Valentine, Zhaohui Gu et al. · 2018 · Blood
53. Childhood B-acute lymphoblastic leukemia: a genetic update
    Jennifer S. Woo, Michael O. Alberti, Carlos A Tirado · 2014 · Experimental Hematology and Oncology
54. Global efforts toward the cure of childhood acute lymphoblastic leukaemia
    Ching‐Hon Pui, Jun J.J. Yang, Nickhill Hitesh Bhakta, Carlos Rodriguez Galindo · 2018 · The Lancet Child & Adolescent Health
55. IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
    Martin Stanulla, Hélène Cavé, Anthony V. Moorman · 2019 · Blood
56. Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
    Lynda M. Vrooman, Lewis B. Silverman · 2016 · Current Hematologic Malignancy Reports
57. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation
    Robin D. Lee, Sarah A. Munro, Todd Philip Knutson, Rebecca S. LaRue, Lynn M. Heltemes-Harris, Michael A. Farrar · 2021 · Nature Communications
58. IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia
    Anthony V. Moorman, Claire J. Schwab, Hannah Ensor, Lisa Jane Russell, Heather Morrison, Lisa Jones, Dino Mašić, Bella Patel, Jacob M. Rowe, Martin S. Tallman et al. · 2012 · Journal of Clinical Oncology
59. How I treat acute lymphoblastic leukemia in older adolescents and young adults
    Emily K. Curran, Wendy Stock · 2015 · Blood
60. Global lactylome reveals lactylation-dependent mechanisms underlying T H 17 differentiation in experimental autoimmune uveitis
    Wei Fan, Xiaotang Wang, Shuhao Zeng, Na Li, Guoqing Wang, Ruonan Li, Siyuan He, Wanqian Li, Jiaxing Huang, Xingran Li et al. · 2023 · Science Advances
61. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B–cell differentiation
    Isabel Ferreirós-Vidal, Thomas Carroll, Ben Taylor, Anna V. Terry, Ziwei Liang, Ludovica Bruno, Gopuraja Dharmalingam, Sanjay P. Khadayate, Bradley S. Cobb, Stephen T. Smale et al. · 2013 · Blood
62. Genomic Characterization of Childhood Acute Lymphoblastic Leukemia
    Charles Grenfell Mullighan · 2013 · Seminars in Hematology
63. Adolescents and Young Adults with Acute Lymphoblastic Leukemia
    Wendy Stock · 2010 · Hematology
64. Molecular classification improves risk assessment in adult BCR-ABL1– negative B-ALL
    Elisabeth M. Paietta, Kathryn G. Roberts, Victoria Wang, Zhaohui Gu, Georgina A. N. Buck, Deqing Pei, Cheng Cheng, Ross L. Levine, Omar Ibrahim Abdel-Wahab, Zhongshan Cheng et al. · 2021 · Blood
65. The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
    Elias Joseph Jabbour, Nicholas James Short, Nitin Jain, Fadi Haddad, Mary Alma Welch, Farhad Ravandi, Hagop M. Kantarjian · 2023 · Journal of Hematology & Oncology
66. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology
    Daniel A. Arber, Michael J. Borowitz, Melissa H. Cessna, Joan E. Etzell, Kathryn K. Foucar, Robert Paul Hasserjian, J. Douglas Rizzo, Karl S. Theil, Sa A. Wang, Anthony T. Smith et al. · 2017 · Archives of Pathology & Laboratory Medicine
67. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia
    Vikki Rand, Helen Parker, Lisa Jane Russell, Claire J. Schwab, Hannah Ensor, Julie Anne Elizabeth Irving, Lisa Jones, Dino Mašić, Lynne Minto, Heather Morrison et al. · 2011 · Blood
68. Evaluation of multiplex ligation‐dependent probe amplification as a method for the detection of copy number abnormalities in B‐cell precursor acute lymphoblastic leukemia
    Claire J. Schwab, L. R. Jones, H. Morrison, Sarra L. Ryan, HaciAli Yigittop, J. P. Schouten, Christine J. Harrison · 2010 · Genes Chromosomes and Cancer
69. Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.
    Kathryn G. Roberts, Yung‐Li Yang, Debbie Payne-Turner, Wenwei Lin, Jacob K. Files, Kirsten M. Dickerson, Zhaohui Gu, Jack Taunton, Laura J. Janke, Taosheng Chen et al. · 2017 · Europe PMC (PubMed Central)
70. Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
    Allison Barz Leahy, Kaitlin J. Devine, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda M. DiNofia, Lisa Wray, Susan R. Rheingold, Colleen A. Callahan, Diane Baniewicz et al. · 2021 · Blood
71. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia
    Chiara Palmi, Elena Vendramini, Daniela Silvestri, Giulia Longinotti, D Frison, Gunnar Cario, C Shochat, Martin Stanulla, Vincenzo Rossi, A.M. Di Meglio et al. · 2012 · Leukemia
72. Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
    Dario Campana · 2009 · Hematology/Oncology Clinics of North America
73. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
    Srividya Swaminathan, Chuanxin Huang, Huimin Geng, Zhengshan Chen, Richard C. Harvey, Huining Kang, Carina Ng, Bjoern Titz, Christian Hurtz, Firas Sadiyah et al. · 2013 · Nature Medicine
74. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes
    Jasmine C. Y. Wong, Victoria L. Bryant, Tamara Westover, Jing Ma, Michael Walsh, Jason R. Schwartz, Maria del pilar Alzamora, Charles Grenfell Mullighan, Mignon L. Loh, Raul Correa Ribeiro et al. · 2018 · JCI Insight
75. Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
    Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O’Brien, Barbara L. Asselin, Uma H. Athale, Luis Antonio Clavell et al. · 2018 · Blood Advances
76. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
    Marketa Kubricanova Zaliova, Jan Stuchlý, Lucie Winkowska, Alena Musilová, Karel Fišer, Martina Slámová, Júlia Starková, Martina Vašková, Ondřej Hrušák, Lucie Šrámková et al. · 2019 · Haematologica
77. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
    Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele Kay Fielding, Robin Foà, Sebastian Giebel, Dieter F. Hoelzer, Mathilde Hunault et al. · 2024 · Blood
78. Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Dario Campana · 2008 · Seminars in Hematology
79. The genomic landscape of acute lymphoblastic leukemia in children and young adults
    Charles Grenfell Mullighan · 2014 · Hematology
80. Detection of prognostically relevant genetic abnormalities in childhood B‐cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin‐Frankfürt‐Münster study group
    Christine J. Harrison, Oskar A. Haas, Jochen Harbott, Andrea Biondi, Martin Stanulla, Jan Trka, Shai Izraeli · 2010 · British Journal of Haematology
81. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
    Trudy Buitenkamp, Rob Pieters, N E Gallimore, Arian van der Veer, Jules P.P. Meijerink, H. Berna Beverloo, M Zimmermann, Válerie de Haas, Sue M. Richards, Ajay J Vora et al. · 2012 · Leukemia
82. Predicting relapse risk in childhood acute lymphoblastic leukaemia
    David T. Teachey, Stephen P. Hunger · 2013 · British Journal of Haematology
83. Our changing view of the genomic landscape of cancer
    Daphne W. Bell · 2009 · The Journal of Pathology
84. NUP98 ‐ NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia
    Norio Shiba, Hitoshi Ichikawa, Tomohiko Taki, Hyuntae Park, Aoi Jo, Sachiyo Mitani, Tohru Kobayashi, Akira Shimada, Manabu Sotomatsu, Hirokazu Arakawa et al. · 2013 · Genes Chromosomes and Cancer
85. Emerging Roles of the EBF Family of Transcription Factors in Tumor Suppression
    Daiqing Liao · 2009 · Molecular Cancer Research
86. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling
    Lilian Kuster, Reinhard Grausenburger, Gerhard Fuka, Ulrike Kaindl, Gerd Krapf, Andrea Inthal, Georg Mann, Maximilian O. Kauer, Johannes Rainer, Reinhard Kofler et al. · 2011 · Blood
87. Milestones in the Curability of Pediatric Cancers
    Melissa Maria Hudson, Michael Paul Link, Joseph V. Simone · 2014 · Journal of Clinical Oncology
88. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia
    Giovanni Cazzaniga, Frederik W. van Delft, Luca Lo Nigro, Anthony M. Ford, J Score, Ilaria Iacobucci, Elena Mirabile, Mary Taj, Susan Colman, Andrea Biondi et al. · 2011 · Blood
89. Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros
    Hilde Schjerven, Jami McLaughlin, Teresita L. Arenzana, Seth E. Frietze, Donghui Cheng, Sarah Wadsworth, Gregory W Lawson, Steven J. Bensinger, Peggy Farnham, Owen N. Witte et al. · 2013 · Nature Immunology
90. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia
    Elias Joseph Jabbour, Ching‐Hon Pui, Hagop M. Kantarjian · 2018 · JAMA Oncology
91. Genetic aberrations in paediatric acute leukaemias and implications for management of patients
    Tomasz Szczepański, Christine J. Harrison, Jacques J. M. van Dongen · 2010 · The Lancet Oncology
92. Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
    Ilaria Iacobucci, Shunsuke Kimura, Charles Grenfell Mullighan · 2021 · Journal of Clinical Medicine
93. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
    Judith M. Boer, Arian van der Veer, Dimitris Rizopoulos, Martha Fiocco, Edwin Sonneveld, Hester A. de Groot‐Kruseman, Roland P. Kuiper, Peter M. Hoogerbrugge, Martin A. Horstmann, Marketa Kubricanova Zaliova et al. · 2015 · Leukemia
94. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
    Emmanuelle Clappier, Nathalie Grardel, Marleen H. C. Bakkus, Jérôme Rapion, Barbara De Moerloose, Philippe Kastner, Aurélie Caye‐Eude, Jocelyne Vivent, V. Costa, Alina Ferster et al. · 2015 · Leukemia
95. Unique Characteristics of Adolescent and Young Adult Acute Lymphoblastic Leukemia, Breast Cancer, and Colon Cancer
    James V. Tricoli, Nita L. Seibel, Donald G. Blair, Karen H. Albritton, Brandon Hayes‐Lattin · 2011 · JNCI Journal of the National Cancer Institute
96. Next-Generation Sequencing in Acute Lymphoblastic Leukemia
    Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Francesco Albano · 2019 · International Journal of Molecular Sciences
97. Recent Research Advances in Childhood Acute Lymphoblastic Leukemia
    Ching‐Hon Pui · 2010 · Journal of the Formosan Medical Association
98. Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
    Dario Campana · 2012 · Current Opinion in Hematology
99. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics
    Sarah Kathleen Tasian, Stephen P. Hunger · 2016 · British Journal of Haematology
100. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%
     Verena Mühlbacher, Melanie Zenger, Susanne Schnittger, Sandra Weißmann, Franziska Kunze, Alexander Kohlmann, Frauke Bellos, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach · 2014 · Genes Chromosomes and Cancer